Journal article

TG‐1701, A SELECTIVE BRUTON TYROSINE KINASE (BTK) INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH UBLITUXIMAB AND UMBRALISIB (U2) IN PATIENTS WITH B‐CELL MALIGNANCIES

CY Cheah, W Jurczak, M Lasica, N Wickham, T Wróbel, J Walewski, CK Yannakou, S Cheung, KL Lewis, M Długosz‐Danecka, K Giannopoulos, HP Miskin, J‐P Tang, E Normant, OA O'Connor, AD Ricart, CS Tam

Hematological Oncology | Wiley | Published : 2021